Edition:
United Kingdom

Miraca Holdings Inc (4544.T)

4544.T on Tokyo Stock Exchange

2,858JPY
5:11am BST
Change (% chg)

¥17 (+0.60%)
Prev Close
¥2,841
Open
¥2,846
Day's High
¥2,877
Day's Low
¥2,838
Volume
162,900
Avg. Vol
361,367
52-wk High
¥5,430
52-wk Low
¥2,742

Latest Key Developments (Source: Significant Developments)

Fujirebio Says Entered Into Agreement With Janssen Pharmaceuticals
Thursday, 26 Apr 2018 

April 26 (Reuters) - Miraca Holdings Inc <4544.T>::FUJIREBIO SAYS ENTERED INTO AGREEMENT WITH JANSSEN PHARMACEUTICALS TO DEVELOP & COMMERCIALIZE AMYLOID Β 42/40 RATIO ASSAY.FUJIREBIO - ASSAY INTENDED TO IDENTIFY PATIENTS WHO MAY BENEFIT FROM TREATMENT WITH JANSSEN'S NEW INVESTIGATIONAL ORAL BACE INHIBITOR, ATABECESTAT.  Full Article

Morpho raises 499.7 mln yen through new share issue
Thursday, 7 Dec 2017 

Dec 7(Reuters) - Morpho Inc <3653.T>:Says it issued 100,800 shares at the price of 4,957 yen per share and raised 499.7 million yen in total through private placement to Miraca Holdings Inc <<<4544.T>>>, with payment date on Dec. 7 .  Full Article

Morpho says capital alliance with Miraca Holdings
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Morpho Inc <3653.T>:Says it plans to issue 100,800 shares of its common stock to Miraca Holdings Inc <<<4544.T>>> to raise 499.7 million yen via capital alliance, with payment date of Dec. 7.Says proceeds will be used for R&D investment and working capital .  Full Article

Miraca Holdings to offer early-retirement program
Tuesday, 31 Oct 2017 

Oct 31(Reuters) - Miraca Holdings Inc <4544.T>:Says it will offer an early-retirement program .Offering period from Nov. 20 to Dec. 8.The company expects 350 employees to take the offer.Says the employees who take up the offer will retire on Jan. 31, 2018.  Full Article

Avista Capital Partners to acquire Miraca Life Sciences
Friday, 22 Sep 2017 

Sept 22 (Reuters) - Avista Capital Ii [RIC:RIC:AVAAA.UL]:Avista Capital Partners says ‍Miraca Life Sciences is a wholly-owned subsidiary of Miraca Holdings Inc​.  Full Article

Miraca Holdings says change of unit
Friday, 22 Sep 2017 

Sept 22 (Reuters) - Miraca Holdings Inc <4544.T>:Says co's unit Miraca Life Sciences Inc's parent company CDx Holdings Inc (CDx) will merge with Avista Capital Holdings LP's unit Symphony Merger Sub Inc (Merger Sub) to become one company (CDx & Merger Sub).Says co will hold 15 percent stake in new holding company Symphony Buyer Inc, which will indirectly hold 100 percent in CDx & Merger Sub.Says co will cut all stake in unit Miraca Life Sciences Inc after the merger in November .Says transaction amount is $175.6 million .  Full Article

‍Morphotek announces agreement with Fujirebio Diagnostics to commercialize CA125 II assay as companion diagnostic for Farletuzumab​
Tuesday, 5 Sep 2017 

Sept 5 (Reuters) - Morphotek::Announces agreement with Fujirebio Diagnostics, Inc. to commercialize CA125 II assay as a companion diagnostic for Farletuzumab​.Agreement provides Fujirebio with worldwide license to develop, manufacture and commercialize CA125 II assay as a companion diagnostic​.  Full Article

Miraca Holdings says business transfer between two units
Thursday, 11 May 2017 

May 11(Reuters) - Miraca Holdings Inc <4544.T>:Says a Tokyo-based wholly owned unit FRHD will take over the subsidiary management business from its unit FUJIREBIO Inc., on July 1 .  Full Article

R&I affirms Miraca Holdings's rating at "A" and says stable outlook-R&I
Monday, 17 Apr 2017 

April 17 (Reuters) - Miraca Holdings Inc <4544.T>:* Rating and Investment Information, Inc. (R&I) affirmed the company's rating at "A"-R&I.* Rating outlook stable-R&I.  Full Article

BRIEF-Fujirebio Says Entered Into Agreement With Janssen Pharmaceuticals

* FUJIREBIO SAYS ENTERED INTO AGREEMENT WITH JANSSEN PHARMACEUTICALS TO DEVELOP & COMMERCIALIZE AMYLOID Β 42/40 RATIO ASSAY